Structure Therapeutics (GPCR) Stock Chart & Stock Price History $34.06 +0.12 (+0.35%) (As of 11:51 AM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Structure Therapeutics Stock Price Performance 5 Day Performance+0.56%1 Month Performance-17.50%3 Month Performance-11.08%6 Month Performance-35.65%Year-To-Date Performance-16.73%1 Year Performance-43.03% Receive GPCR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Structure Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address This company will win the AI race (Ad)Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse. You must read this new presentation from Porter Stansberry. GPCR Stock Chart for Tuesday, December, 3, 2024 GPCR Chart by TradingView Structure Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/02/2024$33.15$33.94+2.38%$34.96$32.97586,696 shs$1.94 billion11/29/2024$33.75$33.15-1.78%$34.64$32.83240,485 shs$1.90 billion11/28/2024$33.75$33.75$34.24$33.081.00 million shs$1.93 billion11/27/2024$33.74$33.75+0.03%$34.24$33.081.00 million shs$1.93 billion11/26/2024$34.01$33.74-0.79%$35.31$33.66590,670 shs$1.93 billion11/25/2024$33.41$34.01+1.80%$34.53$33.40955,293 shs$1.95 billion Get the Latest News and Ratings for GPCR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Structure Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/22/2024$30.10$33.41+11.00%$33.99$29.601.21 million shs$1.91 billion11/21/2024$32.71$30.10-7.98%$33.75$29.93821,781 shs$1.72 billion11/20/2024$32.78$32.71-0.21%$33.18$32.04489,266 shs$1.87 billion11/19/2024$31.75$32.78+3.24%$33.36$30.50796,101 shs$1.88 billion11/18/2024$34.17$31.75-7.08%$33.91$29.482.09 million shs$1.82 billion11/15/2024$37.69$34.17-9.34%$37.76$33.921.08 million shs$1.95 billion11/14/2024$36.37$37.69+3.63%$38.45$33.851.16 million shs$2.16 billion11/13/2024$36.97$36.37-1.62%$37.54$36.33342,731 shs$2.08 billion11/12/2024$38.70$36.97-4.47%$38.66$35.90734,444 shs$2.11 billion11/11/2024$38.02$38.70+1.79%$40.06$37.76562,693 shs$2.21 billion11/08/2024$38.35$38.02-0.86%$38.58$37.41412,567 shs$2.17 billion11/07/2024$38.35$38.35$39.26$38.18515,720 shs$2.19 billion11/06/2024$39.30$38.35-2.42%$42.20$38.04858,880 shs$2.19 billion11/05/2024$39.74$39.30-1.11%$40.53$38.33516,386 shs$2.25 billion11/04/2024$41.14$39.74-3.40%$42.22$39.40824,543 shs$2.27 billion Related Companies Legend Biotech Stock Price Chart Jazz Pharmaceuticals Stock Price Chart Madrigal Pharmaceuticals Stock Price Chart Nuvalent Stock Price Chart Elanco Animal Health Stock Price Chart Corcept Therapeutics Stock Price Chart Blueprint Medicines Stock Price Chart Cytokinetics Stock Price Chart Viking Therapeutics Stock Price Chart Ionis Pharmaceuticals Stock Price Chart Receive GPCR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Structure Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GPCR) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Structure Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Structure Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
